We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Quest's $344M Celera Buy Averts Antitrust Hurdle

Law360 (April 13, 2011, 3:21 PM EDT) -- Quest Diagnostics Inc.'s planned $344 million purchase of genetic research and development company Celera Corp. took a step toward completion Wednesday with the expiration of a statutory waiting period for antitrust...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.